Biotech

Prodesse, a developer of assays for infectious disease detection, will add to its offerings the first diagnostic assay using light upon extension (LUX) technology developed by Invitrogen, and in turn expose Invitrogen's technologies to its global distribution capabilities....

The federal government will continue to draw lines around human embryonic stem cell research following President Bush's veto of the Stem Cell Research Enhancement Act. The House of Representatives fell well short of the two-thirds required to override....

Centricity, the brand name for GE Healthcare's Electronic Health Record, has won the seal of approval from a federal commission that was established to reduce the risk for hospitals and physicians that implement Electronic Health Records....

The United States Senate, defying the threat of a presidential veto, voted overwhelmingly to modify President Bush's ban on new federal funding for embryonic stem cell research. However, the 63 votes in favor of a less restrictive policy is not enough to override a promised...

These are heady days for TomoTherapy, the Madison-based medical device manufacturer that recently opened a new production facility. But the company's top executives say they don't need to come calling on Wall Street, at least not yet....

Taking yet another opportunity to promote stem cell research, Gov. Jim Doyle urged the United States Senate to modify federal policy on funding for human embryonic stem cell lines. A vote could come Tuesday following 12 hours of Senate debate over two days. ...

Imagine, for a moment, that you're a Wisconsin life sciences company and you have a sales rep in biotech hotbeds like San Francisco or Boston. Sound like a dream? Madison's NeoClone is trying to see if it can become a reality with the help of...